International Portugal’s second shot at legalizing cannabis could be thwarted by stigma Politicians' views on pot are years behind, advocates say, in the country widely known for being years ahead on decriminalization Kathryn TindaleJune 24, 2021
Analysis Writedowns and growing pains ahead for Tilray 2.0, analyst says But Chris Damas of the BCMI Cannabis Report notes the Aphria-merged firm will command a strong presence in Europe's medical cannabis market Jared GnamMay 3, 2021
Industry update Tilray stock soars 40% on UK supply deal with Grow Pharma The BC-based producer continues global expansion flurry since unveiling merger deal with Aphira Jared GnamFebruary 9, 2021
Industry update Tilray first company approved to sell medical cannabis in Portugal Propelled by its GMP-certified facility in Portugal, the BC-based producer says it now sells weed in 16 countries Jared GnamFebruary 1, 2021
Industry update Tilray and Aphria unveil merger plan to create world’s biggest weed firm But the $5B all-stock deal raised doubts if two bloated producers could combine to become anything better Jared GnamDecember 16, 2020
Canada Tilray Backs First Human Study on Cannabis in Breast Cancer Patients Tilray shares jumped after announcing it successfully imported medical cannabis into the U.S. in support of a new clinical trial on its use for... Jared GnamOctober 25, 2019
Canada Tilray Slides On US$35-Million Q2 Loss Despite Revenue Beat Shares of the B.C.-based pot producer tumbled after it posted a wider-than-expected loss for the second quarter and despite revenues nearly doubling from the... David JAugust 14, 2019
Canada Tilray Adds Outdoor Cannabis Production Space in Portugal The B.C.-based pot company adds nearly 50 acres of outdoor production in Portugal to further supply the European Union medical cannabis market. Jared GnamAugust 7, 2019